Fidelity International
CGON icon

Fidelity International’s CG Oncology CGON Stock Holding History

Fidelity International’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.93K Hold
126
– – ﹤0.01% 1122
2026
Q2 		$8.95K Hold
126
– – ﹤0.01% 1131
2026
Q1 		$8.53K Buy
+126
New +$7.14K ﹤0.01% 1089

Other funds holding CGON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Fidelity International's CGON Position: Q3 2026 in Review

Fidelity International held its CG Oncology (CGON) position steady in Q3 2026 at 126 shares worth $8.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Fidelity International first reported a position in CGON in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.95K in Q2 2026. 103 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Fidelity International held 126 shares of CG Oncology worth $8.93K as of Q3 2026.
  • Fidelity International left its CG Oncology share count unchanged in Q3 2026.
  • CG Oncology made up ﹤0.01% of Fidelity International's portfolio in Q3 2026, its #1122 holding.
  • Fidelity International first reported a position in CG Oncology in Q1 2026 and has held it in 3 quarters since.
  • Fidelity International's CG Oncology position peaked at $8.95K in Q2 2026.
  • 103 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Fidelity International's 13F filing for Q3 2026, filed 10 Nov 2026.